Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2013 1
2014 2
2016 1
2017 2
2018 1
2020 4
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Lipid-based biomarkers for CVD, COPD, and aging - A translational perspective.
Ekroos K, Lavrynenko O, Titz B, Pater C, Hoeng J, Ivanov NV. Ekroos K, et al. Prog Lipid Res. 2020 Apr;78:101030. doi: 10.1016/j.plipres.2020.101030. Epub 2020 Apr 25. Prog Lipid Res. 2020. PMID: 32339553 Free article. Review.
This has recently been demonstrated by the identification of selective ceramides for prediction of cardiovascular mortality, enabling improved risk assessment of cardiovascular disease compared with conventional clinical markers. ...
This has recently been demonstrated by the identification of selective ceramides for prediction of cardiovascular mortality, enabling …
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
Shlobin OA, Shen E, Wort SJ, Piccari L, Scandurra JA, Hassoun PM, Nikkho SM, Nathan SD. Shlobin OA, et al. Pulm Circ. 2024 Jan 10;14(1):e12310. doi: 10.1002/pul2.12310. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38205098 Free PMC article. Review.
Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with significant morbidity and mortality. Until recently, the studies of pulmonary vasodilator therapy in PH-ILD have been largely disapp …
Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with …
The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
King CS, Shlobin OA. King CS, et al. Chest. 2020 Oct;158(4):1651-1664. doi: 10.1016/j.chest.2020.04.046. Epub 2020 May 7. Chest. 2020. PMID: 32387520 Review.
Development of PH-ILD is associated with increased need for supplemental oxygen, reduced mobility, and decreased survival. A high index of suspicion is required to make the diagnosis, given the substantial overlap in symptoms with those of ILD without PH. ...
Development of PH-ILD is associated with increased need for supplemental oxygen, reduced mobility, and decreased survival. A high ind …
MLK3 regulates fMLP-stimulated neutrophil motility.
Polesskaya O, Wong C, Lebron L, Chamberlain JM, Gelbard HA, Goodfellow V, Kim M, Daiss JL, Dewhurst S. Polesskaya O, et al. Mol Immunol. 2014 Apr;58(2):214-22. doi: 10.1016/j.molimm.2013.11.016. Epub 2014 Jan 3. Mol Immunol. 2014. PMID: 24389043 Free PMC article.
Deficiency of B vitamins leads to cholesterol-independent atherogenic transformation of the aorta.
Almer G, Opriessnig P, Wolinski H, Sommer G, Diwoky C, Lechleitner M, Kolb D, Bubalo V, Brunner MS, Schwarz AN, Leitinger G, Schoiswohl G, Marsche G, Niedrist T, Schauer S, Oswald W, Groselj-Strele A, Paar M, Cvirn G, Hoefler G, Rechberger GN, Herrmann M, Frank S, Holzapfel GA, Kratky D, Mangge H, Hörl G, Tehlivets O. Almer G, et al. Biomed Pharmacother. 2022 Oct;154:113640. doi: 10.1016/j.biopha.2022.113640. Epub 2022 Sep 5. Biomed Pharmacother. 2022. PMID: 36081286 Free article.
Elevated plasma homocysteine is an independent risk factor for atherosclerosis and is strongly linked to cardiovascular mortality. However, the role of homocysteine in atherosclerosis is still insufficiently understood. ...
Elevated plasma homocysteine is an independent risk factor for atherosclerosis and is strongly linked to cardiovascular mortality. Ho …
Utilization of risk assessment tools in management of PAH: A PAH provider survey.
Sahay S, Balasubramanian V, Memon H, Poms A, Bossone E, Highland K, Kay D, Levine DJ, Mullin CJ, Melendres-Groves L, Mathai SC, Soto FJ, Shlobin O, Elwing JM. Sahay S, et al. Pulm Circ. 2022 Apr 8;12(2):e12057. doi: 10.1002/pul2.12057. eCollection 2022 Apr. Pulm Circ. 2022. PMID: 35514787 Free PMC article.
A goal-oriented approach to achieve low risk status has been associated with improved survival. A variety of risk stratification tools are available, but use is low. ...
A goal-oriented approach to achieve low risk status has been associated with improved survival. A variety of risk stratification tool …
Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study.
Stanevich OV, Fomina DS, Bakulin IG, Galeev SI, Bakin EA, Belash VA, Kulikov AN, Lebedeva AA, Lioznov DA, Polushin YS, Shlyk IV, Vorobyev EA, Vorobyeva SV, Surovceva TV, Bakulina NV, Lysenko MA, Moiseev IS. Stanevich OV, et al. BMC Infect Dis. 2021 Dec 22;21(1):1277. doi: 10.1186/s12879-021-06982-z. BMC Infect Dis. 2021. PMID: 34937556 Free PMC article.
The control group was selected 1:1 from 1355 dexamethasone-treated patients and was matched by main clinical and laboratory parameters predicting survival. Recruitment period was April 7, 2020 through September 9, 2020. ...
The control group was selected 1:1 from 1355 dexamethasone-treated patients and was matched by main clinical and laboratory parameters predi …
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
Shlobin OA, Kouranos V, Barnett SD, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Lower EE, Engel PJ, Wort J, Price L, Wells AU, Nathan SD, Baughman RP. Shlobin OA, et al. Eur Respir J. 2020 May 14;55(5):1901747. doi: 10.1183/13993003.01747-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32139456 Free article.
In the 159 precapillary patients, the Kaplan-Meier-adjusted 1-, 3- and 5-year transplant-free survival was 89.2%, 71.7% and 62.0%, respectively. Kaplan-Meier-adjusted 1-, 3- and 5-year transplant-free survival in the incident group was 83.5%, 70.3% and 58.3%, respec …
In the 159 precapillary patients, the Kaplan-Meier-adjusted 1-, 3- and 5-year transplant-free survival was 89.2%, 71.7% and 62.0%, re …
19 results